89 related articles for article (PubMed ID: 27040338)
1. A Sponsor's Perspective on the Contribution of Regulatory-Required Observational Post-Marketing Studies to Understanding Human Drug Product Benefit/Risk in Japan.
Wolter KD; Kamatani A; Suzuki Y; Imaeda T; Dagher R; Safferman A; Junor R
Pharmaceut Med; 2024 May; 38(3):217-224. PubMed ID: 38555545
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Regulatory Reforms in China on Drug Lag: The Role of Clinical Development Strategies.
Han Y; Jiang R; Li J; Wang Y; Shao R; Xie J
Clin Pharmacol Ther; 2024 Jun; 115(6):1400-1407. PubMed ID: 38429944
[TBL] [Abstract][Full Text] [Related]
3. Synthetic Approaches to the New Drugs Approved During 2022.
France SP; Lindsey EA; McInturff EL; Berritt S; Carney DW; DeForest JC; Fink SJ; Flick AC; Gibson TS; Gray K; Johnson AM; Leverett CA; Liu Y; Mahapatra S; Watson RB
J Med Chem; 2024 Mar; 67(6):4376-4418. PubMed ID: 38488755
[TBL] [Abstract][Full Text] [Related]
4. Global Medical Device Clinical Trials Involving Both the United States and Japan: Key Considerations for Development, Regulatory Approval, and Conduct.
Iwamoto S; Cavanaugh K; Malone M; Lottes A; Thatcher R; Kumar K; Rowland S; Fearnot N; Uchida T; Iwaishi C; Senshu K; Konishi R; Ikeda K; Suzuki Y; Ikeno F; Tamura A; Ho M; Ohashi M; Katayama H; Krucoff MW
Cardiovasc Revasc Med; 2023 Jul; 52():67-74. PubMed ID: 36870799
[TBL] [Abstract][Full Text] [Related]
5. [Introduction and Reflection on Novel Medical Device Regulatory Science Tool MDDT].
Teng Y; Sheng H; Liu Y
Zhongguo Yi Liao Qi Xie Za Zhi; 2023 Nov; 47(6):674-679. PubMed ID: 38086727
[TBL] [Abstract][Full Text] [Related]
6. Bayesian statistics and clinical trial designs for human cells and tissue products for regulatory approval.
Jokura Y; Yano K; Watanabe N; Yamato M
Regen Ther; 2016 Dec; 5():86-95. PubMed ID: 31245506
[TBL] [Abstract][Full Text] [Related]
7. Lessons learned from the investigational device exemption review of Children's Oncology Group trial AAML1031.
Meshinchi S; Hunger SP; Aplenc R; Adamson PC; Jessup JM
Clin Cancer Res; 2012 Mar; 18(6):1547-54. PubMed ID: 22422407
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic applications of carbohydrate-based compounds: a sweet solution for medical advancement.
Lalhmangaihzuala S; Vanlaldinpuia K; Khiangte V; Laldinpuii Z; Liana T; Lalhriatpuia C; Pachuau Z
Mol Divers; 2024 Mar; ():. PubMed ID: 38554170
[TBL] [Abstract][Full Text] [Related]
9. Current situation and issues regarding termination of risk management plans in Japan.
Kameyama N; Hosaka A; Maeda H
Front Med (Lausanne); 2024; 11():1387652. PubMed ID: 38873195
[TBL] [Abstract][Full Text] [Related]
10. Rigour and science in drug regulatory approval.
Abbasi K
J R Soc Med; 2023 Oct; 116(10):323. PubMed ID: 37961884
[No Abstract] [Full Text] [Related]
11. Combination products: modernizing the regulatory paradigm.
Hunter NL; Sherman RE
Nat Rev Drug Discov; 2017 Aug; 16(8):513-514. PubMed ID: 28496147
[TBL] [Abstract][Full Text] [Related]
12. An overview of Food and Drug Administration regulation of drugs, biologics, and devices to be used for management of periodontal diseases.
Tylenda CA; Weintraub M
Ann Periodontol; 1997 Mar; 2(1):11-7. PubMed ID: 9151539
[TBL] [Abstract][Full Text] [Related]
13. Regulatory approval pathways for anticancer drugs in Japan, the EU and the US.
Nagai S; Ozawa K
Int J Hematol; 2016 Jul; 104(1):73-84. PubMed ID: 27084259
[TBL] [Abstract][Full Text] [Related]
14. [Regulatory Science in the Review of Drugs and Medical Devices].
Koide A
Yakugaku Zasshi; 2016; 136(4):557-62. PubMed ID: 27040338
[TBL] [Abstract][Full Text] [Related]
15. [Pharmaceuticals and Medical Devices Agency (PMDA)'s new action for Pharmaceutical Affairs Consultation on Research and Development (R&D) Strategy].
Masuyama K
Yakugaku Zasshi; 2013; 133(2):183-6. PubMed ID: 23370511
[TBL] [Abstract][Full Text] [Related]
16. [Twenty-year History and Future Challenges in Transparency Enhancement of Review Process for Approval: Focus on Public Release of Review Reports regarding New Drugs and Medical Devices].
Morimoto K; Kawasaki S; Yoshida Y
Yakushigaku Zasshi; 2015; 50(1):64-77. PubMed ID: 26427100
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
